Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)

Overview

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)

This competitive grant program seeks to support independent medical education activities that will increase knowledge of new guideline-based treatment recommendations. Projects considered for grant support will focus on one or more of the following:

Application of guideline recommended care in first-line locally advanced or metastatic urothelial carcinoma (la/mUC):

* Holistic management of patients with la/mUC, including but not limited to:
* selection and sequencing of therapies
* early identification, management, and monitoring of adverse events
* adverse event mitigation strategies to employ before or during treatment
* Best practices for multidisciplinary teams to deliver safe and effective care for la/mUC patients, particularly community and rural practice settings with a focus on advanced practice provider education
* Strengthening shared decision-making between health care providers and patients/patient caregivers

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

* The following types of organizations may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
* Please note:
* Only organizations are eligible to receive grants, not individuals or medical practice groups.
* If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
* The project/program lead must be an employee or contractor of the requesting organization.
* Requesting organization must be legally able to receive award funding directly from Pfizer Inc.
* For projects offering continuing education credit, the requesting organization must be accredited.
* Examples of educational formats that will be considered under this RFP include but are not limited to:
* Multi-activity or tiered education that builds over time such as a series of activities or curriculum-based learning.
* Tethered programs, incorporating patients/caregivers into learning activities.
* On agenda educational sessions during live conferences or satellite symposia adjacent to major conferences (including those through Spring of 2026).
* Grand Rounds or tumor boards.
* Expert interviews recorded at live conferences, conference coverage reviews.
* Online articles, training courses, webinars, podcasts.
* All learning resources such as videos, infographics, animations.